Oxytocin Market

Global Oxytocin Market Size, Share & Trends Analysis Report, by Indication (Antepartum, Postparttum), By Distribution Channel (Hospital Pharmacies, Drug Stores, Online Pharmacies), Forecast (2021-2027)

Published: Oct 2021 | Report Code: OMR2024382 | Category : Pharmaceuticals | Delivery Format: /

The Global Oxytocin Market is estimated to grow at a CAGR of 5.1% during the forecast period. The hypothalamus produces oxytocin, which is secreted by the pituitary gland. This vital hormone is involved in the process of childbirth, and also aids male reproduction Knowledge of oxytocin will help in better health management and a better understanding of how the human body works. During childbirth, oxytocin is crucial for triggering womb contractions in women. The hormone causes the uterine muscles to contract, triggering labour. It also boosts the synthesis of prostaglandins, which speeds up labour and increases contractions. Although, oxytocin function is less important in men, it does have a role in sperm movement. It also appears to have an effect on testosterone production in the testes.

An increasing prevalence of pregnancy problems, a rising number of births globally, and expanding knowledge of induced labour and breastfeeding are some of the factors driving the market expansion. The major factors driving the growth of the oxytocin market include rising spending power, especially in developing countries, and increasing awareness of pregnancy care products among women, as well as an increase in women's literacy rates and well-developed distribution channels for oxytocin products. In recent years, plenty of neuroscientific studies have looked into new possibilities in novel treatment approaches for mental diseases, with oxytocin assisting in the discovery of new therapeutic targets. As a result, the oxytocin market has opened up new revenue opportunities in autism, depression, schizophrenia, borderline personality disorder, and social anxiety disorders.

For Instance, an antepartum oxytocin injection (synthetic) is used to start or improve uterine contractions when an early vaginal delivery is desired or regarded appropriate for foetal or maternal reasons. Exogenous oxytocin has been approved by the FDA for stimulating uterine contractions in the antepartum period, in order to achieve a successful vaginal delivery of the fetus.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segments Covered

o By Indication

o By Distribution channel

    • Regions Covered

o North America

o Europe

o Asia-Pacific

o Rest of the world

    • Competitive Landscape: Bimeda, GlaxoSmithKline PLC, Grindeks, JHP Pharmaceuticals, KAPL among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Oxytocin Market Segmentation

By Indication

    • Antepartum

    • Postpartum

By Distribution Channel

    • Hospital Pharmacies

    • Drug Stores

    • Online Pharmacies

Global Oxytocin Market by Region

North America       

    • United States 

    • Canada

Europe

    • Germany

    • United Kingdom

    • France

    • Spain

    • Italy

    • Rest of Europe

Asia-Pacific    

    • China

    • Japan

    • India

    • Rest of Asia-Pacific

Rest of the World

    • Latin America

    • Middle East and Africa